Related Experiment Video
Updated: May 10, 2026
04:09
Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel Film
Published on: December 13, 2024
Oromucosal film preparations: classification and characterization methods
Maren Preis1, Christina Woertz, Peter Kleinebudde
1Heinrich Heine University of Düsseldorf, Institute of Pharmaceutics and Biopharmaceutics, Germany. maren.preis@hhu.de
Expert Opinion on Drug Delivery
|June 18, 2013
Summary
New oromucosal film preparations require standardized quality control methods. This review discusses suitable characterization techniques for buccal and orodispersible films to ensure product quality and patient safety.
Area of Science:
- Pharmaceutical Technology
- Drug Delivery Systems
Background:
- Regulatory authorities have expanded the range of oromucosal preparations to include buccal films and orodispersible films.
- These novel film preparations are increasingly available in the market and pharmacopoeias.
- Current official monographs lack standardized characterization methods and quality specifications due to their novelty.
Purpose of the Study:
- To review and recommend appropriate methods for characterizing oromucosal film preparations.
- To provide guidance on biorelevant characterization and quality control for these dosage forms.
- To address the specific requirements and challenges associated with film dosage forms.
Main Methods:
- Discussion of commonly used dissolution tests and their limitations for film preparations.
- Presentation of alternative and suitable characterization methods for oromucosal films.
- Reflection on the essential requirements for film dosage forms.
Main Results:
- Standard dissolution tests for other dosage forms are not always transferable to oromucosal films.
- Guidance is provided on selecting appropriate methods for film characterization and quality control.
- The review highlights the need for specific approaches to assess the quality of film preparations.
Conclusions:
- Oromucosal film preparations present significant opportunities in pharmaceutical development.
- While literature offers suggestions for quality control, standardized tests are currently unavailable.
- Precise definition of standards and quality requirements by regulatory authorities is crucial for these innovative products.
Related Concept Videos
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:14Drug Dissolution: Requirements and Profile Comparison
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...